testo-alternativo
Dermatology at the Crossroads: Sustainability and Breakthrough Therapies

Advancements in Dermatology: A Weekly Review

Dermatologia e Venerologia

Dermatology at the Crossroads: Sustainability and Breakthrough Therapies

This week, we explore how dermatology is addressing its environmental footprint while advancing innovative treatments. From sustainability initiatives to the surprising benefits of diabetes medications in skin care, vaccination updates, and long-term safety data on atopic dermatitis therapies—discover the developments shaping tomorrow’s dermatological practice.

Login or Register to listen to this episode

Bibliography

- Niebel D, Tso S, Parker ER, et al. Environmental Impact of Dermatology and Action Towards It: A Narrative Review. Int J Dermatol. 2025;64(8):1388-1400. doi:10.1111/ijd.17810


- Pantazopoulos D, Gouveri E, Papi M, et al. GLP-1 Receptor Agonists, DPP-4 Inhibitors and the Skin—Diabetes Meets Dermatology: A Brief Narrative Review. Adv Ther. 2025;42(8):3621-3633. doi:10.1007/s12325-025-03257-w


- Stoevesandt J, Schmalzing M, Mohme S, et al. Vaccination in dermatology 2025: Update considering current recommendations of the German Standing Committee on Vaccination. J Dtsch Dermatol Ges. 2025;23(8):925-930. doi:10.1111/ddg.15785


- Paller AS, Eichenfield LF, Irvine AD, et al. Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic Dermatitis. Allergy. 2025;80(8):2213-2224. doi:10.1111/all.16512


- Bizjak M, Aerts O, Pesqué D, et al. Contact Urticaria and Related Conditions: Clinical Review. Contact Dermatitis. 2025;93(2):87-107. doi:10.1111/cod.14794

Comments

Please Login to leave a comment.

No comments yet. Be the first to comment!